Benjamin Goeppert, Trine Folseraas, Stephanie Roessler, Matthias Kloor, Anna‐Lena Volckmar, Volker Endris, Ivo Buchhalter, Albrecht Stenzinger, Krzysztof Grzyb, Marit M. Grimsrud, Barbara Gornicka, Erik Seth, Gary M. Reynolds, Andre Franke, Daniel N. Gotthardt, Arianeb Mehrabi, Angela Cheung, Joanne Verheij, Johanna Arola, Heikki Mäkisalo, Tor J. Eide, Sören Weidemann, John C. Cheville, Giuseppe Mazza, Gideon M. Hirschfield, Cyriel Y. Ponsioen, Annika Bergquist, Piotr Milkiewicz, Konstantinos N. Lazaridis, Christoph Schramm, Michael P.

Samar H. Ibrahim, Maureen M. Jonas, Sarah A. Taylor, Luz Helena Gutierrez Sanchez, Jaqueline L. Wolf, Shikha S. Sundaram – 10 January 2020 – Liver diseases affecting the mother and infant dyad may present in the perinatal period from 20 weeks of gestation to 28 days of life. This review will focus on the current approach to neonatal acute liver failure and the progress made in the diagnosis and management of gestational alloimmune liver disease. It will highlight mother‐to‐child transmission of viral hepatitis, both management and public health implications.

Shabir Hassan, Shikha Sebastian, Sushila Maharjan, Ami Lesha, Anne‐Marie Carpenter, Xiuli Liu, Xin Xie, Carol Livermore, Yu Shrike Zhang, Ali Zarrinpar – 7 January 2020

Leonard U. Hess, Glòria Martrus, Annerose E. Ziegler, Annika E. Langeneckert, Wilhelm Salzberger, Hanna Goebels, Adrian F. Sagebiel, Sven H. Hagen, Tobias Poch, Gevitha Ravichandran, Martina Koch, Christoph Schramm, Karl J. Oldhafer, Lutz Fischer, Gisa Tiegs, Laura Richert, Madeleine J. Bunders, Sebastian Lunemann, Marcus Altfeld – 6 January 2020 – The transcription factor promyelocytic leukemia zinc finger protein (PLZF) is involved in the development of natural killer (NK) cells and innate lymphoid cells, including liver‐resident NK cells in mice.

Austin Lin, Lindsay Alpert, John Hart, Christopher Chapman, Anjana A. Pillai – 6 January 2020

Carla W. Brady – 6 January 2020 – Liver disease in pregnancy may present as a disorder that is unique to pregnancy or as an acute or chronic liver disease occurring coincidentally in pregnancy. Hepatic diseases that are unique to pregnancy include hyperemesis gravidarum; preeclampsia/eclampsia; the syndrome of hemolysis, elevated liver enzymes, and low platelets; intrahepatic cholestasis of pregnancy; and acute fatty liver of pregnancy.

Carla W. Brady – 6 January 2020 – Liver disease in pregnancy may present as a disorder that is unique to pregnancy or as an acute or chronic liver disease occurring coincidentally in pregnancy. Hepatic diseases that are unique to pregnancy include hyperemesis gravidarum; preeclampsia/eclampsia; the syndrome of hemolysis, elevated liver enzymes, and low platelets; intrahepatic cholestasis of pregnancy; and acute fatty liver of pregnancy.

Ashley Spann, Angeline Yasodhara, Justin Kang, Kymberly Watt, Bo Wang, Anna Goldenberg, Mamatha Bhat – 6 January 2020 – Machine learning (ML) utilizes artificial intelligence to generate predictive models efficiently and more effectively than conventional methods through detection of hidden patterns within large data sets. With this in mind, there are several areas within hepatology where these methods can be applied. In this review, we examine the literature pertaining to machine learning in hepatology and liver transplant medicine.

Austin Lin, Lindsay Alpert, John Hart, Christopher Chapman, Anjana A. Pillai – 6 January 2020

Xinxing Tantai, Na Liu, Jinhai Wang – 6 January 2020